Rhumbline Advisers Acquires 1,924 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
9 hours ago • Google News
Madrigal Pharmaceuticals Inc (MDGL)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 9.49B
P/E Ratio
0.00
Revenue (TTM)
$ 515.55M
Volume
0
52W High
$ 457.16
52W Low
$ 200.63
Dividend Yield
0.00%
Beta
-1.02
Technicals
50-Day MA
363.866
200-Day MA
325.7045
52 Week High
457.16
52 Week Low
200.63
About MDGL
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
Employees
528
Headquarters
West Conshohocken, PA
CEO
Mr. William J. Sibold